“Lu AF82422 in Healthy Non-Japanese and Japanese Subjects and in Patients With Parkinson's Disease”
The purpose of this study is to investigate the safety of a single dose of Lu AF82422, how well it is tolerated, how the drug effects the body and what the body does to the drug in healthy non-Japanese and Japanese subjects and in patients with Parkinson's disease
Drug - Lu AF82422
Lu AF82422 - concentrate for solution for infusion; vials containing 50mg/ml, single dose
Drug - Placebo
placebo - concentrate for solution for infusion, single dose
Interventional, Randomized, Double-blind, Sequential-group, Placebo-controlled, Single-ascending-dose Study Investigating the Safety, Tolerability and Pharmacokinetic and Pharmacodynamic Properties of Lu AF82422 in Healthy Non-Japanese and Japanese Subjects and in Patients With Parkinson's Disease
NCT03611569
b4x8Vb